Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
Background: The COPCOV study (chloroquine/ hydroxychloroquine prevention of coronavirus disease), which started recruitment in April 2020, is a multi-country double-blind, randomised, placebo-controlled trial which is being conducted in healthcare facilities involved in COVID-19 case management. Par...
Saved in:
Main Author: | Perrone C. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/83865 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Coronavirus disease 2019–COVID-19
by: Kuldeep Dhama, et al.
Published: (2020) -
Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
by: Dashraath, Pradip, et al.
Published: (2023) -
Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand
by: Jackrapong Bruminhent, et al.
Published: (2020) -
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a placebo-controlled prophylaxis study (COPCOV)
by: William Hk Schilling, et al.
Published: (2022) -
Pharmacological treatment for the novel coronavirus disease 2019 (COVID-19 infection)
by: Nattapong Tidwong, et al.
Published: (2020)